← Back
Data updated: Mar 10, 2026
DOW PHARM
Dermatology
DOW PHARM is a pharmaceutical company focused on Dermatology. Key products include ALTRENO.
1954
Since
7
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
2 drugs
Pipeline Strength Pro
Loading...
Discontinued (5)
Company Info
- First Approval
- 1954-04-19
- Latest
- 2018-08-23
- Applications
- 9